4//SEC Filing
Schranz Jennifer 4
Accession 0001104659-20-010902
CIK 0001641640other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:56 PM ET
Size
5.4 KB
Accession
0001104659-20-010902
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-01-31$1.35/sh−4,295$5,798→ 53,705 total
Holdings
- 58,000
Ordinary Shares
Footnotes (1)
- [F1]The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 52,500 previously reported restricted stock units and 5,500 ordinary shares.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001735382
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 8:56 PM ET
- Size
- 5.4 KB